Myra Vision

Developer of a medical device for the treatment of glaucoma

placeCampbell, California, United States calendar_todayFounded 2019 groups25 employees language myravision.com

Social engagement

Social engagement: 2K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include The Capital Partnership, PA MedTech VC Fund, Cormorant Asset Management.

Investor typeCountShare
Venture capital114%
Private equity229%
Accelerator & incubator114%
Other / undisclosed343%

Recent activity

15 Jun 2026
Event
AECOS (American-European Congress of Ophthalmic Surgery)
9 Jun 2026
Event
AECOS 2026 European Symposium
30 Jan 2026
Product launch
CalibreyeTM Titratable Glaucoma TherapyTM (TGT) surgical system
Coming soon